Kevin Mc Culloch Xeris Biopharma Holdings, Inc. (XERS) insider trading activity

XERS Quotes by TradingView

Kevin Mc Culloch is Officer of Xeris Biopharma Holdings, Inc.. Currently has a direct ownership of 1.7 Million shares of XERS, which is worth approximately $15.7 Million. The most recent transaction as insider was on Oct 02, 2025, when has been sold 733 shares (Common Stock) at a price of $8.31 per share, resulting in proceeds of $6,091. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.7M
0.48% 3M change
6.15% 12M change
Total Value Held $15.7 Million

Kevin McCulloch Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 02 2025
SELL
Payment of exercise price or tax liability
$6,091 $8.31 p/Share
733 Reduced 0.04%
1,700,426 Common Stock
Aug 01 2025
SELL
Payment of exercise price or tax liability
$78,822 $5.38 p/Share
14,651 Reduced 0.85%
1,701,159 Common Stock
Jun 13 2025
BUY
Open market or private purchase
$109,500 $4.38 p/Share
25,000 Added 1.44%
1,708,585 Common Stock
Apr 02 2025
SELL
Payment of exercise price or tax liability
$3,774 $5.15 p/Share
733 Reduced 0.04%
1,683,585 Common Stock
Jan 31 2025
SELL
Payment of exercise price or tax liability
$278,157 $3.56 p/Share
78,134 Reduced 4.95%
1,499,318 Common Stock
Jan 31 2025
BUY
Grant, award, or other acquisition
-
185,000 Added 9.9%
1,684,318 Common Stock
Jan 03 2025
SELL
Payment of exercise price or tax liability
$88,448 $3.61 p/Share
24,501 Reduced 1.53%
1,577,452 Common Stock
Aug 01 2024
BUY
Grant, award, or other acquisition
-
150,000 Added 8.56%
1,601,953 Common Stock
KM

Kevin Mc Culloch

Officer
Chicago, IL

Track Institutional and Insider Activities on XERS

Follow Xeris Biopharma Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XERS shares.

Notify only if

Insider Trading

Get notified when an Xeris Biopharma Holdings, Inc. insider buys or sells XERS shares.

Notify only if

News

Receive news related to Xeris Biopharma Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XERS